# A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects

> **NCT05735249** · PHASE1 · COMPLETED · sponsor: **Arisan Therapeutics, Inc.** · enrollment: 94 (actual)

## Conditions studied

- Healthy Adult Participants

## Interventions

- **DRUG:** ARN-75039 oral capsules
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05735249
- **Lead sponsor:** Arisan Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-23
- **Primary completion:** 2025-03-28
- **Final completion:** 2025-03-28
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05735249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05735249, "A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05735249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*